Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT07813585

Impact of Demography, Ethnicity, Co-morbidities and Inequalities on Outcomes in High-Grade Lymphoma Across the UKCHART Network

Conditions: Impact of Demography, Ethnicity, Co-morbidities and Inequalities on Outcomes in High-Grade Lymphoma Across the UKCHART Network

Sex: All
Ages: 18 Years – N/A
Enrollment: 2000
Sponsor: The Royal Wolverhampton Hospitals NHS Trust

Summary

DECIPHER is a retrospective multicentre observational cohort study using data collected across UKCHART sites. The study will evaluate the impact of ethnicity, socioeconomic deprivation and comorbidity burden on treatment delivery and outcomes in adults diagnosed with DLBCL between 2021 and 2025.

Eligibility Criteria

Inclusion Criteria: * Adults aged ≥18 years. * Newly diagnosed DLBCL. * Managed within participating UKCHART sites. Exclusion Criteria: * Transformed lymphoma. * Insufficient linkage data.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07813585). StuddyBuddy aggregates publicly available trial information.